These regulatory professionals are joining the RAPS Board of Directors in 2027
Three accomplished regulatory affairs professionals are set to join the RAPS Board of Directors, our society’s governing body, in 2027.
Silu Zhang, Jennifer Neff, and Raymond Seda will join the board as directors starting on 1 January 2027, and current board member Jennifer Paine will move from director to the role of board president. In 2027, Diana Salditt will take the helm as chair of the RAPS board.
Jennifer Neff, RAC-Global, RCC-MDR, Vice President of Medical Devices at Entourage
As the vice president of medical devices for Entourage, Jennifer Neff supports leading life science companies in Europe as a consultant. She previously held regulatory, clinical, and quality positions at Sartorius Stedim Biotech, bess AG, Bayer Health Care, Parexel Consulting, NOXXON Pharma AG, Berlin Heart GmbH, and Biotronik GmbH & Co KG. Prior to joining the industry, Jennfer worked as a veterinarian in small and large animal practices and for the primate genetics division of the German Primate Center. Jennifer is a RAPS Fellow, and she holds the RAC-Global and RCC-MDR credentials. She lives in Berlin, Germany.
Raymond Seda, FRAPS, RAC-US, Vice President, Quality Operations at Integra LifeSciences
As vice president of quality operations at Integra LifeSciences, Raymond Seda leads global quality for Integra LifeSciences’ specialty surgery division across the US (including Puerto Rico), Europe, Israel, and China. He previously held roles at Medtronic, Zimmer Biomet, and Johnson & Johnson, where he led multi-site teams as they optimized quality systems and ensured regulatory compliance in global markets. He has previously served one term on the RAPS Board of Directors and served as a member of the RAPS Finance Committee and RAPS Convergence Planning Committee. Raymond is a Six Sigma Black Belt and a RAPS Fellow, and he holds the RAC-US credential. He lives in Puerto Rico, US.
Silu Zhang, RAC-Devices, RCC-IVDR, RCC-MDR, Vice President, Global Regulatory, Quality and Clinical Affairs at Simcere Diagnostics
As vice president, global regulatory, quality, and clinical affairs at Simcere Diagnostics, Silu Zhang leads regulatory, quality, clinical, and compliance strategy across a diverse portfolio of IVD devices, companion diagnostics, and other products across global markets. She has held previous roles at O-Two Medical Technologies, Actalent, Beckman Coulter Diagnostics, and Reckitt. Silu started her career as a government regulator for China’s National Medical Products Administration (NMPA), where she reviewed high-risk medical devices and diagnostic systems, represented China in global regulatory collaborations, and more. She is a recipient of the RAPS Community Leadership Award and holds the RAC-Devices, RCC-IVDR, and RCC-MDR credentials. She is also a contributing author to the RAPS book, Fundamentals of Medical Device Regulations: A Global Perspective. She lives in Toronto, Canada.
At the end of 2026, Ayse Baker and Lawrence Liberti will complete their terms as directors and Jethro Ekuta will conclude his term as chair of the board.
“Thank you for your service to RAPS and the regulatory affairs profession,” said RAPS Executive Director Bill McMoil. “You have each contributed to our profession’s continued advancement, and our society is in a better place thanks to your efforts.”
Learn more about the RAPS Board of Directors and their roles and responsibilities.